Literature DB >> 29950525

Lung cancer stage-shift following a symptom awareness campaign.

Martyn P T Kennedy1, Leanne Cheyne2, Michael Darby3, Paul Plant4, Richard Milton5, Jonathan M Robson1, Alison Gill6, Puneet Malhotra7, Victoria Ashford-Turner1, Kirsty Rodger1, Elankumaran Paramasivam1, Annette Johnstone3, Bobby Bhartia3, Shishir Karthik3, Catherine Foster8, Veronica Lovatt9, Francesca Hewitt10, Louise Cresswell11, Victoria H Coupland12, Margreet Lüchtenborg12,13, Ruth H Jack12, Henrik Moller14, Matthew E J Callister1.   

Abstract

BACKGROUND: Lung cancer outcomes in the UK are worse than in many other developed nations. Symptom awareness campaigns aim to diagnose patients at an earlier stage to improve cancer outcomes.
METHODS: An early diagnosis campaign for lung cancer commenced in Leeds, UK in 2011 comprising public and primary-care facing components. Rates of community referral for chest X-ray and lung cancer stage (TNM seventh edition) at presentation were collected from 2008 to 2015. Linear trends were assessed by χ2 test for trend in proportions. Headline figures are presented for the 3 years pre-campaign (2008-2010) and the three most recent years for which data are available during the campaign (2013-2015).
FINDINGS: Community-ordered chest X-ray rates per year increased from 18 909 in 2008-2010 to 34 194 in 2013-2015 (80.8% increase). A significant stage shift towards earlier stage lung cancer was seen (χ2(1)=32.2, p<0.0001). There was an 8.8 percentage point increase in the proportion of patients diagnosed with stage I/II lung cancer (26.5% pre-campaign vs 35.3% during campaign) and a 9.3% reduction in the absolute number of patients diagnosed with stage III/IV disease (1254 pre-campaign vs 1137 during campaign).
INTERPRETATION: This is the largest described lung cancer stage-shift in association with a symptom awareness campaign. A causal link between the campaign and stage-shift cannot be proven but appears plausible. Limitations of the analysis include a lack of contemporary control population. © Article author(s) (or their employer(s) unless otherwise stated in the text of the article) 2018. All rights reserved. No commercial use is permitted unless otherwise expressly granted.

Entities:  

Keywords:  lung cancer

Mesh:

Year:  2018        PMID: 29950525     DOI: 10.1136/thoraxjnl-2018-211842

Source DB:  PubMed          Journal:  Thorax        ISSN: 0040-6376            Impact factor:   9.139


  26 in total

1.  Sensitivity of chest X-ray for detecting lung cancer in people presenting with symptoms: a systematic review.

Authors:  Stephen H Bradley; Sarah Abraham; Matthew Ej Callister; Adam Grice; William T Hamilton; Rocio Rodriguez Lopez; Bethany Shinkins; Richard D Neal
Journal:  Br J Gen Pract       Date:  2019-11-28       Impact factor: 5.386

Review 2.  What should governments be doing to prevent diabetes throughout the life course?

Authors:  Patrick Timpel; Lorenz Harst; Doreen Reifegerste; Susann Weihrauch-Blüher; Peter E H Schwarz
Journal:  Diabetologia       Date:  2019-08-27       Impact factor: 10.122

3.  Author response.

Authors:  Stephen Bradley
Journal:  Br J Gen Pract       Date:  2022-02-24       Impact factor: 5.386

4.  Establishing scanning protocols for a CT lung cancer screening trial in the UK.

Authors:  Gareth R Iball; Michael Darby; Rhian Gabe; Philip A J Crosbie; Matthew E J Callister
Journal:  Br J Radiol       Date:  2021-09-24       Impact factor: 3.039

5.  Role of chest radiographs in early lung cancer detection.

Authors:  Junghyun Kim; Kwan Hyoung Kim
Journal:  Transl Lung Cancer Res       Date:  2020-06

6.  Management of patients with early stage lung cancer - why do some patients not receive treatment with curative intent?

Authors:  Ross Lawrenson; Chunhuan Lao; Leonie Brown; Lucia Moosa; Lynne Chepulis; Rawiri Keenan; Jacquie Kidd; Karen Middleton; Paul Conaglen; Charles de Groot; Denise Aitken; Janice Wong
Journal:  BMC Cancer       Date:  2020-02-10       Impact factor: 4.430

7.  Approaches to diagnosing cancer earlier in general practice.

Authors:  Jon D Emery
Journal:  Br J Gen Pract       Date:  2021-04-29       Impact factor: 5.386

8.  Engaging high-risk groups in early lung cancer diagnosis: a qualitative study of symptom presentation and intervention preferences among the UK's most deprived communities.

Authors:  Grace McCutchan; Julia Hiscock; Kerenza Hood; Peter Murchie; Richard D Neal; Gareth Newton; Sara Thomas; Ann Maria Thomas; Kate Brain
Journal:  BMJ Open       Date:  2019-05-22       Impact factor: 2.692

Review 9.  Recognising Lung Cancer in Primary Care.

Authors:  Stephen H Bradley; Martyn P T Kennedy; Richard D Neal
Journal:  Adv Ther       Date:  2018-11-29       Impact factor: 3.845

10.  Presentation of lung cancer in primary care.

Authors:  D P Weller; M D Peake; J K Field
Journal:  NPJ Prim Care Respir Med       Date:  2019-05-22       Impact factor: 2.871

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.